Clinical Oncology
Volume 18, Issue 5 , Pages 378-382 , June 2006

Small Cell Lung Cancer Treated in Southeast Wales

  • J.F. Lester

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • Corresponding Author InformationAuthor for correspondence: Jason F. Lester, Department of Oncology, Velindre Hospital, Whitchurch road, Cardiff CF14 7XL, UK. Tel: +44-2920-196159.
    • ,
  • E. Hudson

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • M. Flubacher

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • F. Macbeth

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • J. Baker

      Affiliations

    • Llandough Hospital, Cardiff, UK
    • ,
  • R. Wade

      Affiliations

    • Welsh Cancer Intelligence and Surveillance Unit, Cardiff, UK
    • ,
  • D. Morrey

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • L. Hanna

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • A. Brewster

      Affiliations

    • Velindre Hospital, Cardiff, UK
    • ,
  • S.J. Linnane

      Affiliations

    • Llandough Hospital, Cardiff, UK

Received 16 October 2005 ,Revised 6 February 2006 ,Accepted 19 March 2006.

References 

  1. Boyle P, Gandini S, Gray N. Epidemiology of lung cancer: a century of great success and ignominious failure. In:  Hansen H editors. IASLC textbook of lung cancer. London: Martin Dunitz; 2000;p. 13–26
  2. Agra Y, Pelayo M, Sacristan M, Sacristan A, Serra C, Bonfill X. Chemotherapy versus best supportive care for extensive small cell lung cancer. The Cochrane Library. 2006;Issue 1:Chichester, UK: John Wiley and Sons Ltd.
  3. Thatcher N, Clark PI, Girling DJ, et al. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet. 1996;348:563–566
  4. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618–1624
  5. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;341:476–484
  6. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1993;11:336–344
  7. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol. 1997;15:893–900
  8. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol. 2002;20:3054–3060
  9. Laskin JJ, Erridge SC, Coldman AJ, et al. Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer. 2004;43:7–16
  10. Albain KS, Crowley JJ, LeBlanc M, et al. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol. 1990;8:1563–1574
  11. Bremnes RM, Sundstrom S, Aasebo U, et al. Norwegian Lung Cancer Study Group. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter studywith minimum 5 year follow-up. Lung Cancer. 2003;39:303–313
  12. James LE, Spiro S, O'Donnell KM, et al. A randomised study of timing of thoracic irradiation in small cell lung cancer (SCLC) – study 8. Lung Cancer. 2003;41:S23
  13. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer. 1987;59:1874–1881
  14. Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–271

PII: S0936-6555(06)00113-0

doi: 10.1016/j.clon.2006.03.016

Clinical Oncology
Volume 18, Issue 5 , Pages 378-382 , June 2006

Article Tools

* Image Usage & Resolution